Reply
- PMID: 35491264
- DOI: 10.1016/j.jaci.2022.03.027
Reply
Comment on
-
Clarifying the categorization of anaphylaxis as an adverse event during oral immunotherapy.J Allergy Clin Immunol. 2022 Jul;150(1):229-230. doi: 10.1016/j.jaci.2022.02.032. Epub 2022 Apr 28. J Allergy Clin Immunol. 2022. PMID: 35491265 No abstract available.
Publication types
LinkOut - more resources
Full Text Sources